Search results for "Prognostic models"

showing 8 items of 8 documents

Use of Machine Learning and Artificial Intelligence to Drive Personalized Medicine Approaches for Spine Care

2020

Personalized medicine is a new paradigm of healthcare in which interventions are based on individual patient characteristics rather than on “one-size-fits-all” guidelines. As epidemiological datasets continue to burgeon in size and complexity, powerful methods such as statistical machine learning and artificial intelligence (AI) become necessary to interpret and develop prognostic models from underlying data. Through such analysis, machine learning can be used to facilitate personalized medicine via its precise predictions. Additionally, other AI tools, such as natural language processing and computer vision, can play an instrumental part in personalizing the care provided to patients with …

Traumatic spinal cord injuryPrognosiPsychological interventionPatient characteristicsDiseaseSpinal cord injuryMachine learningcomputer.software_genreSpinal DiseaseMachine Learning03 medical and health sciences0302 clinical medicineArtificial IntelligenceHealth careFunctional StatuMedicineHumansSpine carePrecision MedicineDegenerative cervical myelopathyPrognostic modelsSpinal Cord InjuriesNatural Language ProcessingSpinal Cord Injuriebusiness.industryPrognosisPersonalized medicineFunctional Status030220 oncology & carcinogenesisSurgeryFunctional statusSpinal DiseasesNeurology (clinical)Personalized medicineArtificial intelligenceSpondylosisbusinesscomputerSpinal Cord Compression030217 neurology & neurosurgeryHuman
researchProduct

Prognosis of resected intrahepatic cholangiocarcinoma

2017

Introduction. Complete resection stands as the only curative option for intrahepatic cholangiocarcinoma (IHCC). Still, prognosis remains poor after resection due to a recurrence rate over 60% leading to actual 5-year survival rates below 20%. Reliable prognostic estimation and better understanding of tumor biology would be of interest for improving IHCC prognosis.Methods. Using clinical and biological data from two large cohort of resected IHCC (MSKCC, n=189 and AFC, n=522), three objectives have been explored. First, assessing the performances of different published prognostic models. Second, defining the reliability of preoperative prognostic estimation using imaging, tumoral genomic prof…

[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologySurvivalPrognostic modelsModèles pronostiquesRésectionGenomic profilingResectionCirculating microRNAGénomiqueCholangiocarcinome intrahépatiqueSurvie[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyIntrahepatic cholangiocarcinomaMicroARN circulant
researchProduct

Comparison of prognostic models in patients with advanced Hodgkin disease

2001

Several prognostic systems have been elaborated for patients with Hodgkin disease (HD) over the last 12 years, but early identification of a reasonably large group of both low and high risk, advanced stage patients remains unsatisfactory.Seven well known models were applied to 516 patients with advanced HD, with 315 patients used for the study sample and 201 patients used for the test sample. Individual performances as well as joint performances were analyzed univariately and multivariately in relation to overall survival, recurrence free survival, and time to treatment failure by means of a proportional hazards model.None of the models identified a group containing10% of patients from the …

AdultMaleCancer Researchmedicine.medical_specialtyAdolescentPopulationSample (statistics)DiseaseHodgkin disease; prognosis; modeling; survival; time to treatment failureInternal medicinemedicineHumansIn patientChildeducationTime to treatment failurePrognostic modelsAgededucation.field_of_studyProportional hazards modelbusiness.industryLinear modelMiddle AgedModels TheoreticalPrognosisHodgkin DiseaseSurvival AnalysisSurgeryOncologyFemalebusinessCancer
researchProduct

Stability and Predictors of Poor 6-min Walking Test Performance over 2 Years in Patients with COPD

2020

Poor performance in the 6-min walk test (6MWT &lt

medicine.medical_specialtylcsh:MedicinePulmonary diseaseLogistic regressionArticlemobility activities03 medical and health sciences0302 clinical medicineInternal medicine6MWTMedicineCOPDIn patient030212 general & internal medicinePrognostic modelsCOPDPerformance statusbusiness.industrylcsh:RGeneral Medicinemedicine.disease5STSpredictors030228 respiratory systemTest scorebusiness6 min walking testJournal of Clinical Medicine
researchProduct

Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis

2020

BACKGROUND AND OBJECTIVE MYELOFIBROSIS: is an infrequent chronic myeloproliferative neoplasm. We aimed to describe the clinico-biological characteristics, treatment, and evolutive course of myelofibrosis patients in Spain.; MATERIAL AND METHODS: A total of 1,000 patients from the Spanish Registry of Myelofibrosis diagnosed with primary (n=641) or secondary (n=359) myelofibrosis were analysed.; RESULTS: Median age was 68 years. The frequency of constitutional symptoms, moderate to severe anaemia (Hb<10g/dL), and symptomatic splenomegaly was 35%, 36%, and 17%, respectively. The rate of thrombosis and haemorrhage was 1.96 and 1.6 events per 100 patient-years, respectively. The cumulative incid…

Moderate to severePediatricsmedicine.medical_specialtyConstitutional symptomsbusiness.industrymedicine.diseaseTransplantation03 medical and health sciences0302 clinical medicineChronic Myeloproliferative NeoplasmClinical heterogeneitymedicineElderly people030212 general & internal medicineMyelofibrosisbusinessPrognostic modelsMedicina Clínica (English Edition)
researchProduct

A Statistical Study to Analyze the Impact of External Weather Change on Chronic Pulmonary Infection in South Norway with Machine Learning Algorithms

2021

In this paper, we analyzed the holistic impact of external weather on chronic pulmonary infection in the Agder region with traditional machine learning algorithms. Millions of people are diagnosed with Chronic Obstructive Pulmonary Disease (COPD). Our study is dedicated in the Agder region, the Southern part of Norway. Norway has four seasons – winter (December-February), late winter/spring (March-May), Summer (June-August), and Autumn (September-November) in a year with average annual temperature approx. 7.5 °C | 45.5 °F and an annual rainfall of 1260 mm or 49.6 in. in Kristiansand. As predicted by the World Health Organization (WHO), in 2016, Norway suffered from 8% mortality due to c(1)h…

COPDbusiness.industryLate winterPulmonary diseasePulmonary infectionLogistic regressionmedicine.diseaseMachine learningcomputer.software_genreWorld healthGeographyAir temperaturemedicineArtificial intelligencebusinessAlgorithmcomputerPrognostic models
researchProduct

Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY …

2021

Objectives: We aimed to develop and validate a prediction model, based on clinical history and examination findings on initial diagnosis of coronavirus disease 2019 (COVID-19), to identify patients at risk of critical outcomes. Methods: We used data from the SEMI-COVID-19 Registry, a cohort of consecutive patients hospitalized for COVID-19 from 132 centres in Spain (23rd March to 21st May 2020). For the development cohort, tertiary referral hospitals were selected, while the validation cohort included smaller hospitals. The primary outcome was a composite of in-hospital death, mechanical ventilation, or admission to intensive care unit. Clinical signs and symptoms, demographics, and medical…

Microbiology (medical)medicine.medical_specialtyEvidence-based medicinePrognostic modelsReferralMedicinaCritical IllnessLogistic regressionInitial assessmentRisk Assessmentlaw.inventionlawmedicineHumansMedical historyGeneralizability theoryHospital MortalityRetrospective Studiesbusiness.industryMedicina basada en l'evidènciaCOVID-19Easily obtained clinical variablesGeneral MedicineModels Theoreticalmedicine.diseaseIntensive care unitConfidence intervalHospitalizationInfectious DiseasesSpainEmergency medicineCohortCritical illnessbusinessKidney disease
researchProduct

Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study

2021

Background: Sorafenib is the gold standard therapy for the advanced hepatocellular carcinoma (HCC). No scoring/staging is universally accepted to predict the survival of these patients. Aims: To evaluate the accuracy of the available prognostic models for HCC to predict the survival of advanced HCC patients treated with Sorafenib included in the Italian Liver Cancer (ITA.LI.CA.) multicenter cohort. Methods: The performance of several prognostic scores was assessed through a Cox regression-model evaluating the C-index and the Akaike Information Criterion (AIC). Results: Data of 1129 patients were analyzed. The mean age of patients was 61.6 years, and 80.8% were male. During a median follow-u…

OncologyMaleSurvivalHepatocellular carcinomaCohort study Hepatocellular carcinoma Prognosis Sorafenib SurvivalSeverity of Illness IndexAntineoplastic Agent0302 clinical medicineProspective StudiesLiver NeoplasmsGastroenterologyMiddle AgedSorafenibPrognosisTreatment OutcomeItalyLiver Neoplasm030220 oncology & carcinogenesisHepatocellular carcinomaCohort030211 gastroenterology & hepatologyFemaleLiver cancerCohort studymedicine.drugCohort studySorafenibCohort study; Hepatocellular carcinoma; Prognosis; Sorafenib; Survivalmedicine.medical_specialtyCarcinoma HepatocellularPrognosiSettore MED/12 - GASTROENTEROLOGIAAntineoplastic AgentsRisk Assessment03 medical and health sciencesInternal medicinemedicineHumansneoplasmsPrognostic modelsNeoplasm StagingProportional Hazards ModelsRetrospective StudiesHepatologybusiness.industrySettore MED/09 - MEDICINA INTERNAGold standardmedicine.diseasedigestive system diseasesMulticenter studybusiness
researchProduct